Key Takeaways
-
Begin preparing 12–36 months before a DSO sale, because the changes that grow normalized EBITDA need time to show up in your numbers.
-
Target overhead of 50–55% of collections, hygiene production above 30%, and a payer mix with at least 60% private/PPO patients.
-
Lower owner dependency 18–24 months before going to market by hiring an associate, documenting SOPs, and empowering an office manager.
-
Have 3 years of clean, normalized financials, resolve AR aging beyond 90 days, and address Arizona-specific compliance at least 12 months before a sale.
-
McLerran & Associates runs a competitive, auction-style DSO bid process that can generate multiple offers and stronger outcomes for Arizona sellers.
Talk confidentially with McLerran & Associates about your Arizona practice.
Why Arizona Owners Benefit From Starting 36 Months Before A DSO Sale
Arizona dental practice owners who start 36 months before a DSO sale give themselves time to improve the drivers of normalized EBITDA. Owner dependency, hygiene recall, overhead ratios, and financial documentation usually need 12–36 months to change and then show a clear trend. Early preparation also lets you shape the story your numbers tell.
The value equation in a DSO transaction is normalized EBITDA multiplied by a multiple. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is the buyer’s measure of true operating profit. It reflects what the practice earns after removing personal and non-recurring expenses and replacing your clinical compensation with a market rate, rather than what your tax return shows. Growing normalized EBITDA from $500,000 to $750,000 can match or exceed the impact of a higher multiple. For example, a 15x multiple on $500,000 EBITDA equals $7.5 million, and a 10x multiple on $750,000 EBITDA also equals $7.5 million.
DSO buyers underwrite durable, transferable cash flow. They focus on operational improvements that continue after the owner exits. The specific multiple your practice attracts can depend on size, profitability, and operational quality. In Arizona, practices with $1.5 million or more in annual collections tend to draw interest from the largest national DSO platforms. Practices below $1 million often see a thinner DSO buyer pool, while emerging and regional DSOs typically engage above $1 million and large national DSOs often focus on $1.5 million and above, sometimes $2 million or greater.
The current U.S. dental consolidation rate sits at approximately 35%, and deal volume in the first five months of 2026 involved at least 175 practice locations, so the market remains active. Buyers have also become more selective. About 69% of surveyed DSOs expect their private equity sponsors to moderately or highly increase acquisition activity in 2026, which can create a favorable window for owners of healthy, well-prepared practices.
Get a confidential, data-driven review of your Arizona practice.
36 Months Out: Build The EBITDA Engine
At 36 months out, focus on growing normalized EBITDA. The most effective levers are optimizing overhead, strengthening hygiene production above 30% of collections, and building a payer mix with at least 60% private and PPO patients. These improvements compound over time and show buyers that your cash flow is durable and transferable.
The 50-40-30 rule in dentistry refers to clinical guidelines. It can mean either a cosmetic smile-design reference for contact zones between upper front teeth or a restorative threshold for deciding between a filling and a crown. It does not serve as a practice-management benchmark for staff costs, overhead, and doctor compensation. These are separate concepts from practice management or valuation. For overhead benchmarks, confirm exact ratios for your practice with a dental CPA. The national median dental practice overhead sits at approximately 62% of collections, while institutional buyers often target 50–55%. The gap between those numbers can represent significant enterprise value. On a $2 million collections practice, every 1% reduction in overhead can generate about $160,000 in additional enterprise value at an 8x multiple.
Hygiene functions as the recurring-revenue engine of your practice. Hygiene revenue above 30% of collections is one of the two highest-leverage dental practice value drivers, worth an estimated +0.5x to +1.0x EBITDA multiple. Buyers review hygiene reappointment rate, 6‑month recall compliance, and hygiene-to-restorative conversion rate. Practices below the 30% hygiene-of-collections floor can signal weaker recurring revenue and less transferable patient flow.
Payer mix also plays a major role. A commercial and PPO-heavy payer mix can add roughly +0.5x to a dental practice’s EBITDA multiple, while heavy Medicaid or HMO concentration at 40% or more of collections can compress the multiple by 0.5x–1.0x as buyers model reimbursement risk. Targeting at least 60% private and PPO collections is a practical preparation goal.
The $1.5 million collections threshold often matters as well. Dental practices below approximately $500,000 in adjusted EBITDA often cap at roughly 3x–4x EBITDA because the buyer pool narrows to individual dentists and SBA-financed buyers. Practices below $1.5 million in collections rarely attract a broad, competitive DSO process.
To see where your practice stands, compare your current metrics against these benchmarks and the targets institutional buyers often use:
|
Metric |
Typical Range |
Institutional Buyer Target |
|---|---|---|
|
Staff costs (% of collections) |
25–28% |
20–25% |
|
Total overhead (% of collections) |
60–65% |
50–55% |
|
Hygiene production (% of collections) |
25–33% |
28–35% |
|
Owner production (% of collections) |
Below 70% |
Below 70% |
24 Months Out: Reduce Owner Dependency
At 24 months out, concentrate on reducing owner dependency by hiring an associate, documenting standard operating procedures (SOPs), and empowering an office manager to run the business. This matters because the buyer’s central diligence question is: “What would this practice earn if we had to hire a dentist to replace you?” If owner production exceeds 70% of collections, the answer becomes less favorable and the practice can fall to the lower end of the multiple range for its size band, reflecting a provider-concentration discount of roughly 20–30%.
Owner-dentist production share below 70% of chair time is often the single highest-leverage de-risking variable in dental M&A, worth +0.5x to +1.5x EBITDA, because the DSO can underwrite future cash flow without the selling dentist. Dental practices where the owner performs 90% or more of production can face a 10–20% valuation reduction because buyers struggle to underwrite production revenue that leaves with the seller.
A practical path to reduce owner-dependency risk is to hire a full-time associate at least 18–24 months before a planned sale, document their production trend, and step back from a majority of chair time gradually. Provider risk and clinical continuity now rank among the top reasons DSOs walk from deals, with over-reliance on a single producer often resulting in terminated processes.
Hygiene department strength also belongs in this phase. Recall reappointment above 85% and pre-booking above 85% often separate commodity practices from premium practices. An office manager who truly runs the business, supported by documented SOPs, stable staff tenure, and a plan to remain post-sale, signals to buyers that the practice can operate without the selling doctor at the center of every decision.
Request a comprehensive, sell-side practice valuation.
12 Months Out: Get Buyer-Ready Financials And Arizona Compliance In Order
At 12 months out, assemble 3 years of clean, normalized financial statements with defensible add-backs, resolve accounts receivable (AR) aging beyond 90 days, and address Arizona-specific compliance. An aggressive add-back that a buyer rejects can hurt more than a conservative one.
Dental practice buyers often request 36 months of credit card statements in quality-of-earnings review to identify personal lifestyle expenses run through the practice P&L. Quality-of-earnings review is the buyer’s detailed audit of your financials, and every add-back you claim can be examined line by line. Common defensible add-backs include:
-
Owner-doctor compensation normalization (+$80,000–$300,000)
-
Family members on payroll at above-market rates (+$30,000–$150,000)
-
Owner-occupied building rent above or below market (±$25,000–$120,000)
AR aging deserves direct attention. Patient AR over 90 days should be less than 5% of total patient AR, and any insurance AR dollar sitting past 90 days during institutional diligence is often subject to a dollar-for-dollar reserve reduction against the purchase price. At a 6x EBITDA multiple, $332,000 in 120-plus-day AR does not just cost the practice $332,000, it can cost approximately $2,000,000 in enterprise value, because the reserve reduces EBITDA dollar-for-dollar and that reduced EBITDA is then multiplied by the transaction multiple.
Another metric buyers examine is case acceptance. Case acceptance often falls in the 65%–80% range, while below 45% can signal a warning zone.
Lease terms also influence value. Ensure your commercial lease has more than 5 years remaining, or consider separating and optimizing your real estate strategy before the practice sale. Dental practice buyers may move a practice down within its EBITDA rung for a lease with under 5 years remaining. Payer-contract and re-credentialing reviews should usually begin 180 days before the re-credentialing due or expiration date, with payer-specific materials gathered at 120 days, since many payers re-credential every 2–3 years and processing can take 60–90 days.
Arizona-specific compliance functions as a first-class diligence item. Three Arizona statutes directly affect how DSO deals are structured. Each one imposes specific requirements that buyers can examine during diligence:
-
A.R.S. §32-1213 provides that a “business entity” as defined in A.R.S. §32-1201 may not offer dental services unless it is registered with the Arizona State Board of Dental Examiners and the services are conducted by a licensee, subject to the statute’s stated exceptions. The registration application must identify a dentist authorized and responsible for providing dental services at each office, plus officers, directors, and the custodian of records. This matters in a DSO sale because buyer ownership can be structured through a registered entity, while clinical delivery must remain under licensed-dentist responsibility.
-
A.R.S. §32-1262 establishes the framework for practicing dentistry as a professional corporation, professional limited liability company, or a business organization registered as a business entity under the chapter. The related prohibition on business policies that interfere with a licensee’s clinical judgment appears in A.R.S. §32-1213(L)(2) and §32-1263(C)(16). This means the DSO’s management services organization (MSO) structure cannot direct clinical decisions.
-
A.R.S. §32-1264, titled “Maintenance of records,” governs the creation, maintenance, retention, and release of dental patient records in Arizona. It includes a minimum 6‑year retention period for adult patients’ records after the last date of service. For minor patients, records must be kept until 3 years after the child turns 18 or 6 years after the last service, whichever is later.
Arizona healthcare counsel should review the MSO structure before any letter of intent (LOI) is signed. An LOI is the preliminary agreement that outlines the key terms of a deal before the formal purchase agreement is drafted. Failure to structure the transaction in compliance with these statutes can create regulatory exposure that delays or derails closing.
6 Months Out: Run A Competitive Process
At 6 months out, plan to run a competitive process among vetted buyers rather than negotiating with a single DSO. A structured multi-buyer bid process can generate multiple offers over 45–60 days and often produces a stronger outcome than a one-on-one conversation.
A practice owner who negotiates directly with one DSO usually negotiates from a significant information disadvantage. That DSO negotiates deals every week, while most owners sell once in a lifetime. Dental practices taken to market through a structured multiple-buyer solicitation process receive final sale values that average about 50% above initial unsolicited offers.
McLerran & Associates runs a roughly 45–60-day DSO bid process that typically generates a broad range of offers, with poorly run DSOs excluded from the process. The 2026 M&A environment rewards this approach. The gap between the best and middle-tier offers on any given practice has rarely been wider, with dental practice multiples ranging from 6x to 12x EBITDA depending on practice size and health. Without competition, you have no reliable way to know where your practice falls in that range.
About 78% of DSOs anticipate a recapitalization within 12 to 36 months, so the buyers you negotiate with in 2026 can be under pressure to transact ahead of their own timelines. That pressure can become leverage when multiple buyers compete at the same time. For a detailed comparison of DSO versus private buyer outcomes in Arizona, McLerran & Associates has published dedicated resources on Arizona deal structure and the affiliation process.
Learn how a competitive process could work for your practice.
FAQ
How Long Before A DSO Sale Should You Start Preparing?
Most owners benefit from starting 12 to 36 months before a DSO sale, with the 36‑month window preferred when owner production needs to decrease or hygiene recall needs rebuilding. The operational levers that move normalized EBITDA, such as overhead ratios, hygiene recall, owner dependency, and financial documentation, usually need time to implement and then demonstrate through trending data that buyers review during diligence. A practice that can show 36 months of improving EBITDA trends often holds a stronger negotiating position than one that made changes only in the final quarter before going to market.
How Does Owner Dependency Affect Practice Value?
Owner dependency can directly influence the multiple a buyer is willing to pay. Practices where the owner produces the majority of clinical revenue can face valuation reductions because buyers struggle to underwrite production revenue that leaves with the seller. The buyer’s central diligence question is: “What would this practice earn if we had to hire a dentist to replace you?” Reducing owner dependency by hiring an associate, documenting SOPs, and empowering an office manager to run the business can address this risk before going to market.
What Does A DSO Buyer Look For In Diligence?
DSO buyers review a broad set of operational and financial metrics during diligence. Key items often include hygiene recall and reappointment rates, case acceptance, AR aging over 90 days, owner production percentage, associate production trends, payer mix, lease terms, and 3 years of clean, normalized financial statements. Buyers also review 36 months of credit card statements to identify personal expenses run through the practice P&L and conduct a quality-of-earnings review in which every add-back can be scrutinized. Practices with clean financials, lower owner dependency, strong hygiene recall, and a diversified payer mix tend to attract more competitive offers and fewer post-LOI renegotiations.
Should You Talk To One DSO Or Run A Competitive Process?
Most owners gain more negotiating power by running a competitive process. A structured multi-buyer bid process among vetted buyers creates competition that a single-buyer conversation cannot match. When only one DSO is at the table, that buyer often sets the valuation anchor, deal structure, and timeline. A competitive process among multiple vetted buyers can shift that dynamic in the seller’s favor.
Discuss your timing and options with a sell-side advisor.
Work With The Dental-Only Sell-Side Advisor That Has Evaluated 10,000+ Practices
Arizona dental practice owners who want to prepare for a DSO sale benefit from a sequenced, mechanism-driven roadmap and a sell-side advisor who has seen many versions of this process.
McLerran & Associates is a dental-only sell-side advisor and advocate that has evaluated more than 10,000 practices, completed approximately 2,000 successful practice sales, and closed about $2 billion in transaction volume over roughly 35 years in business. The firm works exclusively on the sell-side and does not represent buyers, so its incentives align with the selling doctor.
McLerran’s process starts with a CPA-led, diligence-grade EBITDA analysis completed up front, so the numbers are more likely to hold when buyers review them and deals are less likely to be renegotiated down later. From that foundation, the firm runs a competitive, auction-like process among a vetted pool of qualified buyers, creating the competition that can produce a better outcome than a single-buyer conversation. The firm reports a transaction rate of approximately 85–90%, compared with an industry norm closer to 35–40%.
McLerran works both private-buyer and DSO transactions in roughly equal measure, at approximately a 50/50 split. This gives Arizona owners a side-by-side comparison that single-lane brokers may not provide. The firm’s Phoenix, Arizona office is led by Brian Carroll and covers the Mountain West.
For owners who are not yet ready to sell, the McLerran M&A Summit (October 29–30, 2026, Austin) is designed for that stage. It is a dental-only event where owners can learn about deal structures, EBITDA, and the DSO landscape before committing to a sale and can receive a complimentary practice valuation.
Start a confidential conversation with McLerran & Associates.
